Delivery Order SPE2DB20D3103-SPE2DB25FN8X4
- Not listed
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,196.24 by the Defense Logistics Agency on August 21, 2025, for the supply of Januvia 100 mg tablets (90-count units). This firm fixed-price, competitively awarded delivery order represents a non-set-aside procurement with an ultimate completion date of August 22, 2025. The award falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order for 90 tablets of Januvia 100 mg by the Defense Logistics Agency (DLA) with a ceiling value of $2,224.88. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of May 7, 2025, and was awarded on May 6, 2025. This award carries no set-aside designation and represents a competitively awarded procurement. The delivery order is issued under...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a $59,928.45 firm fixed-price delivery order by the Defense Logistics Agency (DLA) on September 9, 2025, for the supply of 1,000 tablets of Januvia 100 mg. The contract represents a non-set-aside, competitively awarded delivery order with an ultimate completion date of September 10, 2025, and will be performed at the contractor's Conshohocken facility. This delivery order is...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on July 28, 2025, for the supply of Januvia 100 mg tablets in a quantity of 90 units, with a contract value of $2,182.92. The award utilizes firm fixed pricing with no set-aside designation, indicating competitive selection. This delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at...
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $40,455.90 by the Defense Logistics Agency (DLA) for the supply of 1,000 tablets of Januvia 100 mg, with a completion date of August 8, 2025. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded contract. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency for Januvia 100 mg tablets (90-count units) on July 28, 2025, with a ceiling value of $2,218.86. This is a firm fixed price, non-set-aside contract with a completion date of July 29, 2025. The award was issued from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on September 9, 2025, by the Defense Logistics Agency for the supply of Januvia 50 mg tablets (90-count). The contract is valued at $8,546.07 and features firm fixed-price terms with an ultimate completion date of September 10, 2025. This is a non-set-aside award, indicating it was competitively awarded through open procurement. The delivery order serves as...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $1,091.46 by the Defense Logistics Agency (DLA) on August 4, 2025, for the supply of Januvia 100 mg tablets (90-count). This is a firm fixed price, non-set-aside contract with an ultimate completion date of August 5, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's existing Indefinite Delivery Contract (IDC)...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,487.16 by the Defense Logistics Agency on August 27, 2025, for the supply of Januvia 25 mg tablets (90-count). This is a firm fixed price, non-set-aside contract with an ultimate completion date of August 28, 2025, and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical....
- The Defense Logistics Agency's Medical Supply Chain awarded a competitive delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Januvia 100mg tablets (90-count units) under a firm fixed-price contract valued at $10,040.31. This non-set-aside delivery order is scheduled for completion by October 22, 2025, with performance at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FN8X4Delivery Order
AmerisourceBergen Drug Corp, a leading pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a firm fixed-price delivery order valued at $7,042.85 by the Defense Logistics Agency on May 20, 2025, for the supply of Januvia 100 mg tablets (90-count). The contract is scheduled for completion by May 21, 2025, and involves no set-aside designation, indicating it was competitively awarded. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.9 billion prime vendor agreement running through December 2026 that enables the company to supply a comprehensive range of pharmaceuticals and medical supplies to support military healthcare systems globally. The Defense Logistics Agency's Medical Supply Chain utilizes such delivery orders to fulfill immediate pharmaceutical needs across Department of Defense and federal healthcare beneficiaries. AmerisourceBergen's role as a primary pharmaceutical vendor allows it to rapidly respond to orders for critical medications, including diabetes treatments like Januvia, across military installations, the Defense Health Agency, and other federal healthcare entities. The firm fixed-price structure and expedited completion timeline reflect the essential nature of pharmaceutical procurement within the defense supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.0k | 5/20/25 |